Keyphrases
Alzheimer's Disease
100%
Therapeutic Potential
100%
Apoptosis
100%
Bile Acids
100%
Alzheimer's Disease Treatment
100%
Tauroursodeoxycholic Acid (TUDCA)
57%
Brain Regions
28%
Disease Progression
14%
Inflammation
14%
Therapeutic Use
14%
Therapeutic Strategies
14%
Mitochondrial Function
14%
Molecular Pathogenesis
14%
Cognitive Function
14%
Ursodeoxycholic Acid
14%
Synaptic Dysfunction
14%
Therapeutic Intervention
14%
Potential Therapeutics
14%
Neurological Disorders
14%
Temporal Lobe
14%
Alzheimer's Disease Diagnosis
14%
Life Expectancy
14%
Potent Inhibitor
14%
Cell number
14%
Reactive Oxygen Species Production
14%
Cytochrome c Release
14%
Common Cause
14%
Alzheimer's Disease Brain
14%
Caspase Activation
14%
Induced Aggregation
14%
Post-transcriptional Events
14%
Cell Cycle Proteins
14%
Bax Translocation
14%
Causes of Dementia
14%
Neuronal Cell Death
14%
Neurologic Disorders
14%
Inhibitor of Apoptosis Proteins
14%
Mitochondria-associated Membranes
14%
Large Segment
14%
Apoptotic Markers
14%
Cholinergic System
14%
Survival Pathways
14%
Taurine Conjugate
14%
Cell Cycle Deregulation
14%
People over 65 Years
14%
Tau Toxicity
14%
Pathology Spread
14%
Mitochondrial Failure
14%
Biochemistry, Genetics and Molecular Biology
Bile Acid
100%
Cell Cycle
100%
Tau
50%
Ursodeoxycholic Acid
50%
Inhibitor of Apoptosis
50%
Prevalence
50%
Cell Count
50%
Conjugate
50%
Experimental Model
50%
Mitochondrial Membrane
50%
Cholinergic
50%
Life Expectancy
50%
Cell Death
50%
Caspase
50%
Cognition
50%
Outer Mitochondrial Membrane
50%
Amyloid Protein
50%
Cytochrome C
50%
Neuroscience
Bile Acid
100%
Alzheimer's Disease
100%
Tauroursodeoxycholic Acid
40%
Cell Cycle
20%
Cognitive Function
10%
Mitochondrial Function
10%
Ursodiol
10%
Reactive Oxygen Species
10%
Cholinergic
10%
Basal Forebrain
10%
Temporal Lobe
10%
Neuronal Cell Death
10%
Caspase
10%
Neurological Disorder
10%
Cytochrome C
10%
Mitochondrial Membrane
10%
Amyloid Protein
10%